Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase

MLA

Nathan P Young, et al. “Design of Development Candidate EFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.” Journal of Medicinal Chemistry, vol. 63, no. 11, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f66b781e59583b73ced8e0594522c507&authtype=sso&custid=ns315887.

APA

Nathan P Young, Paul A. Sprengeler, Christopher J. Wegerski, Samuel Sperry, Tran Chinh Viet, Andres Nevarez, Kevin R. Webster, Jocelyn Staunton, Haleigh Howard, Gary G. Chiang, Jim R Appleman, Alan Xiang, Theodore Michels, Reich Siegfried Heinz, Jolene Molter, Garrick Packard, Jeff Clarine, Christian Nilewski, Sarah Fish, … Joan Chen. (2020). Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase. Journal of Medicinal Chemistry, 63(11).

Chicago

Nathan P Young, Paul A. Sprengeler, Christopher J. Wegerski, Samuel Sperry, Tran Chinh Viet, Andres Nevarez, Kevin R. Webster, et al. 2020. “Design of Development Candidate EFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.” Journal of Medicinal Chemistry 63 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f66b781e59583b73ced8e0594522c507&authtype=sso&custid=ns315887.